新焦點(00360.HK)中期公司權益股東應占虧損4.07億元
格隆匯 8 月 31日丨新焦點(00360.HK)公佈,截至2020年6月30日止6個月,持續經營業務收入3.79億元(人民幣,下同),同比下降63.73%;毛利2927.4萬元,同比下降72.45%;公司權益股東應占虧損4.07億元,上年同期為虧損5072.2萬元(含已終止經營);每股基本及攤薄虧損6.011分。
收入主要源於集團受到COVID-19疫情的影響,致使集團批發服務業以及汽車經銷及服務業務於期間內的收入較去年同期下降明顯。
毛利率由2019年同期的10.16%下降到7.72%。毛利和毛利率下降主要源於集團批發服務業以及汽車經銷及服務業務於期間內的收入較去年同期明顯減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.